ClinicalTrials.gg
Not yet recruitingNCT06219850Updated Jan 23, 2024

Physical Exercise, Diet, and Health in People With Type 2 Diabetes: Longitudinal Design of the EDUGUTION Study

An observational study in Fat Burn, Diabetes Mellitus, Type 2 and Cardiovascular Diseases, sponsored by University of Cadiz. Not yet recruiting. Open to participants aged 40 Years to 55 Years. Per ClinicalTrials.gov, last updated 2024-01-23.

Sponsored by University of Cadiz · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 3 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
40 Years to 55 Years
Sex
All
01

Study summary

This longitudinal design study is a continuation of the EDUGUTION project (Ref: PID2019-110063RA-I00; Clinical Trial: NCT05261373), a randomized controlled trial that was approved by the Clinical Research Ethics Committee of Cadiz (Registration No. 92.21; PEIBA No. 1026-N-21) in 2021. The aim of this study was to determine the benefits of three months of intervention with physical exercise and nutritional counseling on health in patients with type 2 diabetes.

Specifically, the aim of the present longitudinal study is to analyze the possible changes that may have occurred in the health and lifestyle habits of the subjects of the EDUGUTION project one year after the end of the study. The tests to be performed are the following: 1) Analysis of sociodemographic information, diet and habits and quality of life with previously validated questionnaires, 2) Fasting blood collection, 3) Anthropometric and body composition assessment, 4) Assessment of physical fitness: manual grip strength and maximal oxygen uptake test.

On the same day in the morning, participants will have to go to the University Hospital of Puerto Real and to the Exercise Physiology Laboratory of the Faculty of Education Sciences of the Puerto Real Campus of the University of Cadiz, one year after the end of the EDUGUTION study. Since there is no intervention, the duration of the study is a single day. In this study 120 patients will participate, the same patients who were included based on the inclusion and exclusion criteria and who completed the EDUGUTION study intervention one year earlier.

Read the detailed description
  1. Sociodemographic Information and Questionnaires

    Sociodemographic information will include gender, age, ethnicity, education, employment and position in the organizational hierarchy, household composition (and person responsible for food shopping and cooking), marital status and information on urban or rural place of residence. With respect to the questionnaires, the following will be included:

    I) Adherence to the Mediterranean diet: the Mediterranean dietary pattern will be determined by a trained professional in a face-to-face interview. It will be established by means of a brief 14-item tool validated in Spanish population. Each question has a score of 0 or 1, since the values of the questionnaire range from 0 to 14. The higher the score, the greater the adherence to the Mediterranean dietary pattern.

    II) Quality of life: Self-reported quality of life will be recorded by applying the Short Form 36-health survey (SF-36) questionnaire previously validated in Spain. The SF-36 is a generic measure of quality of life and has been evaluated for a wide variety of medical conditions, including diabetes. The SF-36 includes 36 questions assessing 8 subscales, scores for each scale range from 0 to 100, with higher scores indicating a higher level of function or well-being.

    III) Bristol Scale: The Bristol visual stool chart will be used to classify stool form and condition, which classifies human stool form into seven groups, with 0 being the major constipation group and 7 being the major diarrhea group.

    IV) Sleep quality: The Pittsburgh sleep quality index previously validated in Spain will be used. The r-MEQ (reduced Morningness-Eveningness Questionnaire) of circadian rhythms will also be used.

  2. Blood collection

    Participants will go to the University Hospital of Puerto Real coordinated by Dr. Florentino Carral in a fasting situation for the extraction of blood by venous blood for the measure of different blood parameters (biochemical parameters, glycosylated hemoglobin, hormones and exosomes). A clinical staff will take blood samples from a forearm vein after 8-10 hours of fasting. The sample will be collected in three Vacutainer plasma separator tubes anticoagulated with EDTA or heparin (5ml per tube) and one Vacutainer serum separator tube (10ml). Blood samples will be centrifuged for separation of plasma and serum, which will be stored at -80 °C until analysis. Plasma glucose and insulin concentrations will be determined by ELISA. These measurements will be used to calculate the HOMA-IR (Homeostatic Model Assessment for Insulin Resistance).

  3. Anthropometry and body composition

    Subsequently, participants will have to go to the exercise physiology laboratory at the UCA in Puerto Real on an empty stomach. First, anthropometry measurements (height and body circumferences) and body composition (weight, body fat, muscle mass and body fluids) will be taken using previously validated 8-electrode multifrequency bioimpedance (TANITA- MC780MA). Patients will wear short, light clothing and assume a specific posture according to the manufacturer's instructions. In addition, 24 hours before the measurement, the following considerations will be followed: (i) refrain from physical exercise, (ii) do not drink alcoholic beverages, (iii) do not drink energy drinks and (iv) fast for at least 8 hours. Participants should urinate just before the measurement to ensure the elimination of body fluids.

  4. Physical fitness: Muscle strength and cardiorespiratory fitness.

Finally, two physical fitness measurements will be performed in the same laboratory. First, muscle strength will be assessed by a manual grip test with a TKK-5401 digital hand-held dynamometer. Cardiorespiratory fitness will be assessed by an incremental test to exhaustion on a cycloergometer using a Jaeger MasterScreen CPX® gas analyzer (CareFusion, San Diego, USA). The test will start with a load of 30W in women and 50W in men, increasing 20W every minute until reaching maximal exhaustion to know the VO2max (maximal oxygen uptake). A pedaling cadence of over 70 rpm should be maintained throughout the test. During the stress test, Dr. Jose Maria Martin Cano (collegiate number: 111108959) will control the heart rate and vital signs to prevent any risk in the test or if there is any emergency situation.

At the end of the measurements, a detailed report with the results of the study will be given to the participants.

02

Conditions studied

  • Fat Burn
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • Metabolism Disorder

Keywords

  • exercise
  • diet
  • metabolism
  • physical fitness
  • cardiometabolic risk
  • gut microbiota
03

In context

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

This study's planned enrollment of 120 is below the median of 300 across 1,749 observational studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

University of Cadiz is the lead sponsor of 55 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The sample of the present study consisted of adults (40-55 years) with type 2 diabetes mellitus or pre-diabetes. Patients must not be insulin dependent and all must be overweight/obese and sedentary people.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Non smoking
  • Non-alcoholic (\<3 standard drinks per day)
  • >25 kg/m maintaining the habitual dietary patterns without a body mass reduction higher than 2% during the last 6 months
  • Not being insulin dependent
  • Absence of injury, disease or disability or other known medical condition which could affect the ability to successfully participate in physical exercise tests
  • Absence of cardiovascular disease (angina, peripheral or cerebro-vascular disease).
  • Absence of neurologic and psychiatric diseases.
  • Absence of respiratory diseases (pulmonary hypertension, , etc.).
  • Absence of other metabolic diseases (hyper/hypo parathyroidism, hyper/hypothyroidism, Cushing's disease, Type 1 diabetes, etc.)
  • Absence of active inflammatory bowel disease
  • Absence of kidney disease
  • Absence of tumours
  • Absence of coagulation dysfunction
  • Not under treatment with medications k known to affect glucose metabolism, recent treatment (within 6 months), or hormone replacement therapy
  • Be able to understand a communication in Spanish or English.

Exclusion criteria

Exclusion Criteria:

  • Failure to complete the EDUGUTION study measurements and the intervention.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • HIIT+Diet

    High-Intensity Interval Training (HIIT) and Nutritional education

    Other: No intervention

  • MICT+Diet

    Moderate-Intensity Continuous Training (MICT) and Nutritional education

    Other: No intervention

  • HIIT+NoDiet

    High-Intensity Interval Training (HIIT) without Nutritional education. The HIIT training consisted of 3 sessions per week in a cycle ergometer, with 1-2 days off between sessions, during a total of 12 weeks under the supervision of a personal trainer. HIIT program consisted of 10 series of 1 min duration at 90% of peak power output, with 60 seconds of rest between sets (estimated total time of the session: 25 minutes).

    Other: No intervention

  • MICT+NoDiet

    Moderate-Intensity Continuous Training (MICT) without Nutritional education. The MICT training consisted of 3 sessions per week in a cycle ergometer during 50 min at moderate intensity, with 1-2 days off between sessions, during a total of 12 weeks under the supervision of a personal trainer.

    Other: No intervention

  • Diet+NoExercise

    Nutritional education without Exercise. The education intervention consisted of individual nutritional counselling. The nutritional education program was conducted every 2 weeks for 12 consecutive weeks, with 20-min counselling sessions by an experienced nutritionist. Participants were provided with an introduction (in an easy-to-understand manner) regarding the association between T2DM, gut microbiome and dietary habits. Firstly, the diet of the patient should be analysed, to determine which aspects can be improved, such as, total calories intake, amount and types of carbohydrates (highlighting the relevance of fibre), etc. Moreover, some suggestions about the combination of foods and culinary technical in order to manage the glycaemic index of foods were provided.

    Other: No intervention

  • Control group

    Neither exercise nor nutritional education

    Other: No intervention

Interventions

  • OtherNo intervention

    The study sample is divided into the six intervention groups of the EDUGUTION study (ClinicalTrials.gov Identifier: NCT05261373), although participants do not receive intervention in the present study, as only a description of the sample is made one year after the EDUGUTION study from a longitudinal perspective.

06

What researchers measure

Primary outcomes

  1. Assessed changes in Plasma Insulin

    The ELISA technique will be used to determine the concentration of plasma insulin (mU/L) in a fasting situation.

    Time frame: 1 year

  2. Assessed changes in Plasma Glucose

    Plasma glucose (mg/dL) will be analysed in a fasting situation.

    Time frame: 1 year

  3. Assessed changes in Glycosylated haemoglobin

    Glycosylated haemoglobin (%) will be analysed in a fasting situation with the ADAMS™ A1C HA-8180V.

    Time frame: 1 year

  4. Assessed changes in Insulin Resistance

    The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) will be calculated using the glucose and insulin variables (HOMA-IR = fasting glucose (mg/dL) x fasting insulin (mU/L)/405).

    Time frame: 1 year

  5. Assessed changes from Body composition: Fatmass and Fat-free mass

    Body composition will be estimated using a multifrequency bioimpedance of 8 electrodes previously validated (TANITAMC780MA). The calculation of impedance can estimate the fat mass and fat-free mass in kilograms. The patients will wear light clothing and will assume a posture in accordance with the manufacturers' instructions. Other previous considerations will be followed 24 hours before the measure: (i) to refrain from vigorous exercise, (ii) to take alcoholic drinks, (iii) to take energy drinks, and (iv) to be in a fasting state for at least 8 hours.

    Time frame: 1 year

  6. Assessed changes in Muscle Strength

    Muscle strength will be assessed by a manual grip test with a TKK-5401 digital hand-held dynamometer.

    Time frame: 1 year

  7. Assessed changes from cardiorespiratory fitness

    Cardiorespiratory fitness will be assessed by an incremental test to exhaustion on a cycloergometer using a Jaeger MasterScreen CPX® gas analyzer (CareFusion, San Diego, USA). The test will start with a load of 30W in women and 50W in men, increasing 20W every minute until reaching maximal exhaustion to know the VO2max (maximal oxygen uptake). A pedaling cadence of over 70 rpm should be maintained throughout the test. During the stress test, Dr. Jose Maria Martin Cano (collegiate number: 111108959) will control the heart rate and vital signs to prevent any risk in the test or if there is any emergency situation.

    Time frame: 1 year

Secondary outcomes

  1. Assessed changes from Sociodemographic situation

    Sociodemographic information will include gender, age, ethnicity, education, employment and position in the organizational hierarchy, household composition (and person responsible for food shopping and cooking), marital status and information on urban or rural place of residence.

    Time frame: 1 year

  2. Assessed changes from self-reported quality of life

    Self-reported quality of life will be registered by applying the Short Form 36-health survey (SF-36) questionnaire previously validated in Spain. The SF-36 is a generic measure of quality of life and has been evaluated for a wide variety of medical conditions, including diabetes. The SF-36 includes 36 questions that evaluate 8 subscales, scores for each scale range from 0 to 100, with higher scores indicating higher level of function or wellbeing. The physical component summary is derived from the 4 subscales of physical functioning, role physical, bodily pain, and general health; while the mental component summary is derived from the subscales of vitality, social functioning, role emotional, and mental health.

    Time frame: 1 year

  3. Assessed changes from Mediterranean diet adherence

    The Mediterranean dietary pattern will be determined by a trained professional in a face-to-face interview. It will be established by means of a brief 14-item tool validated in Spanish population. Each question has a score of 0 or 1, since the values of the questionnaire range from 0 to 14. The higher the score, the greater the adherence to the Mediterranean dietary pattern.

    Time frame: 1 year

  4. Assessed changes in Stool status

    The Bristol visual stool chart will be used to classify stool form and condition, which classifies human stool form into seven groups, with 0 being the major constipation group and 7 being the major diarrhea group.

    Time frame: 1 year

  5. Assessed changes in Sleep quality

    The Pittsburgh Sleep Quality Index (PSQI) previously validated in Spain will be used. The measure consists of 19 individual items, creating 7 components that produce one global score.

    Time frame: 1 year

  6. Assessed changes in Circadian Rhythms

    The r-MEQ (reduced Morningness-Eveningness Questionnaire) of circadian rhythms will be used. Total scores of the 5-item rMEQ range from 4 to 26, whereby a higher score indicates a morningness.

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2024; primary completion for Aug 2024, 6 months later.

Of 436 non-industry observational studies under Diabetes Mellitus, Type 2, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 96. This study's planned 6 months is below that.

Counting every sponsor, half of 606 studies reached it within 32 months; a quarter within 17 and three quarters within 62.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 3, 2023
First posted
Jan 23, 2024
StartEst.
Feb 1, 2024
Primary completionEst.
Aug 1, 2024
CompletionEst.
Jan 1, 2025
Last update
Jan 23, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06219850
Lead sponsor
University of Cadiz
Collaborators
Ministerio de Ciencia e Innovación, Spain
Responsible party
Sponsor
First posted
Jan 23, 2024
Start date
Feb 1, 2024 (estimated)
Primary completion
Aug 1, 2024 (estimated)
Completion
Jan 1, 2025 (estimated)
Last update
Jan 23, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion